The evolution of health research co-production with Indigenous peoples.
Vir’s GSK-allied flu prevention antibody fails PhII, sinking shares and late-stage hope
Vir Biotechnology’s influenza antibody has failed a critical Phase II clinical trial, which could spell bad news for its partner GSK, who has the option